Phase II Study of Adjuvant Everolimus on Pancreatic Neuroendocrine Tumors of the Liver

1 Views
administrator
administrator
07/13/23

Steven Libutti, MD, discusses a Phase II study that examines the effectiveness of adjuvant everolimus on metastatic pancreatic neuroendocrine tumors of the liver.

http://www.montefiore.org/cancer

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next